batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Keytruda/Lynparza link-up disappoints again 9 December 2024 Merck RORs into phase 3 6 December 2024 Merus bags its first approval 5 December 2024 Ipsen finds a MAIT in Biomunex 4 December 2024 Takeda grabs Keros’s Geron challenger 3 December 2024 Eikon becomes a pivotal-stage biotech 2 December 2024 Senti tries to buck the Car-NK trend 2 December 2024 Olema set for an operatic debut at last 2 December 2024 Load More